PBSV — Pharma-Bio Serv Cashflow Statement
0.000.00%
Last trade - 00:00- $10.27m
- -$2.17m
- $9.51m
- 70
- 58
- 39
- 56
Annual cashflow statement for Pharma-Bio Serv, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.05 | -2.09 | 1.01 | 1.31 | -0.778 |
| Depreciation | |||||
| Non-Cash Items | 0.03 | 3.34 | 0.072 | -0.275 | -0.198 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.641 | -0.518 | -0.537 | 0.661 | 0.228 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 1.53 | 0.805 | 0.592 | 1.89 | -0.567 |
| Capital Expenditures | -0.056 | -0.011 | -0.019 | -0.007 | -0.16 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.027 | 1.31 | 0 | -4.21 | -1.2 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.029 | 1.3 | -0.019 | -4.22 | -1.36 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.194 | -1.75 | -3.53 | -1.76 | -1.73 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.65 | 0.33 | -3.01 | -4.02 | -3.68 |